NCT07085169
- Conditions
- Bevacizumab, Colo-rectal Cancer, Colonic Diseases, +12 more
- Locations
-
- SanMing First Hospital Sanming, China
- Ruijin Hospital Shanghai, China
Clinical trial condition
Explore clinical trials studying TAS 102. Study availability and eligibility vary by location and protocol.
NCT07085169
NCT07196345